Market Overview

Joe McCann: Here's How To Play Biotech Market In Earnings Season

Share:
Related IBB
Benzinga's Daily Biotech Pulse: AstraZeneca's Q1, Novartis-Amgen Migraine Drug Approved
Benzinga's Daily Biotech Pulse: ASCO Abstracts, Fibrocell, Ispen And More
Investors bullish on biotechs after Trump drug pricing speech (Seeking Alpha)
Related XBI
Analyst: Trump's 'Naming And Shaming' Campaign To Build Pharma Headline Risk
Mergers, Acquisitions And A Tax Cut: Why This Biotech ETF Can Rebound
Investors bullish on biotechs after Trump drug pricing speech (Seeking Alpha)

Welcome to the February 1 edition of This Week on Estimize. We are pleased to be joined by Joe McCann, founder of Slingshot Insights.

In this episode, Leigh and Joe discuss the current state of the health care industry, and look at quarterly expectations for upcoming biotech and pharma companies such as Gilead Sciences, Inc. (NASDAQ: GILDMerck & Co., Inc (NYSE: MRK), Biogen Inc (NASDAQ: BIIB), Celgene Corporation (NASDAQ: CELG) and Pfizer Inc. (NYSE: PFE).

The preceding article is from one of our external contributors. It does not represent the opinion of Benzinga and has not been edited.

Posted-In: Analyst Color Long Ideas Sector ETFs Media Trading Ideas ETFs

 

Related Articles (BIIB + CELG)

View Comments and Join the Discussion!